Reaction

Genitourinary Tract Neoplasm reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 82 reports · 4 co-occurring drugs

As of the last recalculation, Genitourinary Tract Neoplasm appears in 82 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is LANREOTIDE ACETATE (PRR 411.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Lanreotide Acetate11411.1411.7
Axicabtagene Ciloleucel9259.9260.1
Loperamide Hydrochloride Oral9251.2251.4
Loperamide Hcl9199.3199.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.